WM3670 Viable Cells

Catalog Number: ROC-WM3670-01-0001
Article Name: WM3670 Viable Cells
Biozol Catalog Number: ROC-WM3670-01-0001
Supplier Catalog Number: WM3670-01-0001
Alternative Catalog Number: ROC-WM3670-01-0001
Manufacturer: Rockland Immunochemicals
Category: Zellen/Zellkultur
Conjugation: Unconjugated
Alternative Names: Melanoma, patient derived tumor, tumor models, skin cancer, xenograft
WM3670 is a metastatic human melanoma cell line with epithelial morphology. This cell line features the G469E mutation at codon 469 in the BRAF gene. The G469E mutation results in an amino acid substitution at position 469 in BRAF, from a glycine (G) to a glutamic acid (E). This mutation occurs within the highly conserved GXGXXG motif of the kinase domain. Most mutant BRAF proteins have increased kinase activity and are transforming in vitro. This cell line contains a G12D mutation at position 12 in the N-RAS gene. The G12D mutation results in an amino acid substitution at position 12 in N-RAS, from a glycine (G) to an aspartic acid (D).
Concentration: 1.0 million cells/mL (Count By Hemocytometer)
Buffer: None
Source: Human
Form: Frozen Cell Suspension
Application Notes: The key applications of these cell lines include genetic studies, xenograft production, drug testing, and drug target discovery. These cell line models can be used in various biological assays, and for identifying critical target genes, and cell signaling pathways.
Human melanoma tumor cells with known gene mutations, disease stage, STR, and RPPA profiling